JP Morgan Private Wealth Advisors’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $47.7M | Buy |
+903,792
| New | +$47.4M | 0.14% | 167 |
|
|
2023
Q2 | – | Sell |
-887,244
| Closed | -$44.4M | – | 1536 |
|
|
2023
Q1 | $44.4M | Buy |
887,244
+4,624
| +0.5% | +$218K | 0.09% | 203 |
|
|
2022
Q4 | $40.8M | Buy |
882,620
+5,918
| +0.7% | +$256K | 0.09% | 202 |
|
|
2022
Q3 | $34M | Sell |
876,702
-1,311
| -0.1% | -$52.6K | 0.09% | 208 |
|
|
2022
Q2 | $32.7M | Sell |
878,013
-7,140
| -0.8% | -$291K | 0.08% | 220 |
|
|
2022
Q1 | $39.2M | Buy |
885,153
+24,661
| +3% | +$1.07M | 0.08% | 222 |
|
|
2021
Q4 | $36.6M | Buy |
860,492
+25,047
| +3% | +$1.05M | 0.08% | 228 |
|
|
2021
Q3 | $36.3M | Buy |
835,445
+76,627
| +10% | +$3.39M | 0.09% | 227 |
|
|
2021
Q2 | $32.4M | Buy |
758,818
+163,266
| +27% | +$6.87M | 0.08% | 230 |
|
|
2021
Q1 | $23M | Buy |
595,552
+23,285
| +4% | +$881K | 0.07% | 242 |
|
|
2020
Q4 | $20.6M | Buy |
572,267
+22,271
| +4% | +$803K | 0.07% | 249 |
|
|
2020
Q3 | $21M | Buy |
549,996
+46,341
| +9% | +$1.79M | 0.08% | 209 |
|
|
2020
Q2 | $17.7M | Buy |
503,655
+30,142
| +6% | +$1.09M | 0.08% | 206 |
|
|
2020
Q1 | $15.5M | Buy |
473,513
+45,590
| +11% | +$1.78M | 0.09% | 204 |
|
|
2019
Q4 | $19.4M | Buy |
427,923
+384,569
| +887% | +$16.1M | 0.09% | 201 |
|
|
2019
Q3 | $1.76M | Sell |
43,354
-246
| -0.6% | -$10.4K | 0.01% | 615 |
|
|
2019
Q2 | $1.87M | Buy |
43,600
+16,550
| +61% | +$637K | 0.01% | 605 |
|
|
2019
Q1 | $1.04M | Buy |
27,050
+5,692
| +27% | +$217K | 0.01% | 785 |
|
|
2018
Q4 | $755K | Sell |
21,358
-79,979
| -79% | -$2.9M | ﹤0.01% | 841 |
|
|
2018
Q3 | $3.9M | Sell |
101,337
-1,316
| -1% | -$46K | 0.02% | 483 |
|
|
2018
Q2 | $3.36M | Buy |
102,653
+5,812
| +6% | +$175K | 0.02% | 487 |
|
|
2018
Q1 | $2.65M | Buy |
96,841
+1,471
| +2% | +$40K | 0.02% | 434 |
|
|
2017
Q4 | $2.37M | Sell |
95,370
-3,685
| -4% | -$102K | 0.02% | 456 |
|
|
2017
Q3 | $2.89M | Buy |
99,055
+3,402
| +4% | +$94K | 0.02% | 403 |
|
|
2017
Q2 | $2.65M | Buy |
95,653
+1,699
| +2% | +$45.1K | 0.02% | 408 |
|
|
2017
Q1 | $2.34M | Sell |
93,954
-1,053
| -1% | -$25.6K | 0.02% | 442 |
|
|
2016
Q4 | $2.06M | Sell |
95,007
-47,079
| -33% | -$1.03M | 0.02% | 436 |
|
|
2016
Q3 | $3.38M | Sell |
142,086
-293
| -0.2% | -$6.99K | 0.03% | 338 |
|
|
2016
Q2 | $3.33M | Sell |
142,379
-152,246
| -52% | -$3.29M | 0.03% | 336 |
|
|
2016
Q1 | $5.54M | Buy |
294,625
+122,466
| +71% | +$2.15M | 0.05% | 239 |
|
|
2015
Q4 | $3.17M | Buy |
172,159
+144,381
| +520% | +$2.59M | 0.03% | 290 |
|
|
2015
Q3 | $456K | Sell |
27,778
-215,502
| -89% | -$3.68M | 0.01% | 650 |
|
|
2015
Q2 | $4.31M | Buy |
243,280
+78,354
| +48% | +$1.4M | 0.05% | 258 |
|
|
2015
Q1 | $2.93M | Sell |
164,926
-32,734
| -17% | -$517K | 0.03% | 316 |
|
|
2014
Q4 | $2.62M | Buy |
197,660
+177,282
| +870% | +$2.27M | 0.03% | 338 |
|
|
2014
Q3 | $241K | Sell |
20,378
-958
| -4% | -$12.1K | ﹤0.01% | 917 |
|
|
2014
Q2 | $272K | Sell |
21,336
-5,819
| -21% | -$75.7K | ﹤0.01% | 732 |
|
|
2014
Q1 | $367K | Buy |
27,155
+7,471
| +38% | +$98.1K | 0.01% | 667 |
|
|
2013
Q4 | $237K | Sell |
19,684
-509
| -3% | -$6.01K | ﹤0.01% | 575 |
|
|
2013
Q3 | $237K | Sell |
20,193
-350
| -2% | -$3.79K | 0.01% | 557 |
|
|
2013
Q2 | $190K | Buy |
+20,543
| New | +$174K | ﹤0.01% | 581 |
|
Other funds holding BSX
JP Morgan Private Wealth Advisors's BSX Position: Q3 2023 in Review
JP Morgan Private Wealth Advisors opened a new position in Boston Scientific (BSX) in Q3 2023: 903,792 shares worth $47.7M. The stake represents 0.14% of the portfolio and ranks #167 among its holdings. This is a return to the name: JP Morgan Private Wealth Advisors previously reported a position in BSX as recently as Q1 2023.
JP Morgan Private Wealth Advisors first reported a position in BSX in Q2 2013 and has held it in 41 quarters since. 1,057 funds tracked by Wall St. Rank hold BSX as of Q3 2023.
- JP Morgan Private Wealth Advisors held 903,792 shares of Boston Scientific worth $47.7M as of Q3 2023.
- Boston Scientific was a new JP Morgan Private Wealth Advisors position in Q3 2023.
- Boston Scientific made up 0.14% of JP Morgan Private Wealth Advisors's portfolio in Q3 2023, its #167 holding.
- JP Morgan Private Wealth Advisors first reported a position in Boston Scientific in Q2 2013 and has held it in 41 quarters since.
- 1,057 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2023.
Based on JP Morgan Private Wealth Advisors's 13F filing for Q3 2023, filed 8 Nov 2023.